TREVARUM
Dead · Cancelled DEAD/REGISTRATION/Cancelled/Invalidated
What this record means
The record shows that TREVARUM is a cancelled Principal Register trademark owned by Novartis AG, a Swiss Aktiengesellschaft, and it is no longer live; the cancellation was recorded on Jan 13 2022 after the underlying International Registration was cancelled in whole or in part. The registration covered a very broad range of pharmaceutical goods in International Class 005, including anti‑infectives, anti‑inflammatories, antibiotics, antivirals, cardiovascular and dermatological medicines, inhaled preparations for respiratory diseases, and many other therapeutic categories. Because the listed goods are strictly pharmaceutical, a similar name used for drugs or related health products would create the closest record‑based concern, while uses in unrelated fields would be farther from the scope shown here. The record does not give Novartis control over every possible use of the word “TREVARUM.” No supplemental register action appears, and the prosecution history simply moves from filing in 2019 to registration in 2020 and then cancellation in 2022. The supplied history contains no oppositions, cancellations by third parties, or other enforcement signals. I'd treat this as a meaningful concern if you plan to brand a pharmaceutical product with a name that resembles TREVARUM.
Informational only - not legal advice.Mark Trademark
| Drawing type | 4 - STANDARD CHARACTER MARK |
| Filing basis | Madrid Protocol (§66(a)). |
| Status | U.S. registration cancelled because International Registration cancelled in whole or in part. |
Key dates
| Application filed | Aug 27, 2019 |
| Published for opposition | Jan 07, 2020 |
| Registered (Principal) | Mar 24, 2020 |
| Status date | Jan 13, 2022 |
Goods & services
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Madrid Protocol · §66(a)
| Intl. registration no. | 1108317 |
| Intl. registration date | Jan 13, 2012 |
| Intl. renewal date | Jan 13, 2022 |
| Date of automatic protection | Apr 17, 2021 |
| Notification of designation | Oct 17, 2019 |
| First refusal flag | No |
Owner & representation
| Owner | Novartis AG |
| Address | CH-4002 Basel, SWITZERLAND |
| Entity | AKTIENGESELLSCHAFT (AG) - organized in SWITZERLAND |
| Attorney of record | Maury M. Tepper, III |
| Correspondent | Maury M. Tepper, III |
| Attorney email | m********@*****.com |
| Correspondent email | m********@*****.com |
| Correspondent phone | 9********3 |
| Correspondent address | RALEIGH, NORTH |